MAPT and supranuclear palsy, progressive, 1: Using the next generation tracer 18F-PI-2620 for imaging tau pathology27, we found elevated PET binding in clinically diagnosed CBS and PSP-RS patients, particularly in subcortical predilection sites of 4 R tau pathology.